A detailed history of Nisa Investment Advisors, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 649 shares of SAVA stock, worth $1,654. This represents 0.0% of its overall portfolio holdings.

Number of Shares
649
Previous 632 2.69%
Holding current value
$1,654
Previous $7,000 171.43%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$9.57 - $35.08 $162 - $596
17 Added 2.69%
649 $19,000
Q2 2024

Jul 19, 2024

BUY
$12.35 - $26.11 $592 - $1,253
48 Added 8.22%
632 $7,000
Q1 2024

May 01, 2024

BUY
$18.44 - $26.41 $479 - $686
26 Added 4.66%
584 $11,000
Q4 2023

Jan 25, 2024

BUY
$12.64 - $30.11 $353 - $843
28 Added 5.28%
558 $12,000
Q3 2023

Nov 02, 2023

SELL
$16.64 - $25.32 $8,985 - $13,672
-540 Reduced 50.47%
530 $8,000
Q2 2023

Aug 11, 2023

BUY
$21.59 - $27.88 $2,374 - $3,066
110 Added 11.46%
1,070 $26,000
Q1 2023

May 02, 2023

BUY
$23.46 - $36.44 $15,788 - $24,524
673 Added 234.49%
960 $23,000
Q4 2022

Feb 02, 2023

SELL
$27.82 - $44.16 $11,128 - $17,664
-400 Reduced 58.22%
287 $8,000
Q3 2022

Nov 07, 2022

SELL
$16.33 - $51.06 $7,724 - $24,151
-473 Reduced 40.78%
687 $25,000
Q2 2022

Aug 03, 2022

BUY
$17.22 - $38.47 $15,497 - $34,623
900 Added 346.15%
1,160 $33,000
Q1 2022

Apr 29, 2022

SELL
$32.6 - $53.05 $1,304 - $2,122
-40 Reduced 13.33%
260 $10,000
Q4 2021

Feb 03, 2022

SELL
$36.77 - $90.91 $29,636 - $73,273
-806 Reduced 72.88%
300 $13,000
Q3 2021

Oct 18, 2021

BUY
$41.79 - $135.3 $250 - $811
6 Added 0.55%
1,106 $69,000
Q2 2021

Aug 06, 2021

SELL
$32.15 - $89.72 $749,095 - $2.09 Million
-23,300 Reduced 95.49%
1,100 $94,000
Q1 2021

Apr 26, 2021

BUY
$7.09 - $87.95 $168,033 - $2.08 Million
23,700 Added 3385.71%
24,400 $1.1 Million
Q4 2020

Jan 25, 2021

BUY
$6.79 - $12.25 $4,753 - $8,575
700 New
700 $5,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $102M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.